Evidence map›Paper›PMID 20022538›Full record

ReviewJoint bone spine2010

New insights in synovial angiogenesis.

Zoltán Szekanecz, Timea Besenyei, György Paragh, Alisa E Koch

Open access · greenAbstract readReview
In one paragraph

Review in Joint bone spine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Applications of RNA interference in the treatment of arthritis.Translational research : the journal of laboratory and clinical medicine · 2019
    Review
  10. Electroacupuncture on ST36 and GB39 Acupoints Inhibits Synovial Angiogenesis via Downregulating HIF-1Evidence-based complementary and alternative medicine : eCAM · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Article
  18. Paclitaxel suppresses collagen-induced arthritis: a reevaluation.American journal of translational research · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Zoltán SzekaneczDepartment of Rheumatology, Institute of Medicine, University of Debrecen Medical and Health Sciences Center, 98, Nagyerdei street, Debrecen, H-4032, Hungary. szekanecz.zoltan@med.unideb.hu
Timea Besenyei
György Paragh
Alisa E Koch
University of Debrecen · HUMichigan Medicine · US

Funding

IL-18 in rheumatoid inflammation and angiogenesisR01AR048267 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOCH, ALISA E · 2003 to 2007
$1.4M
NIAMS NIH HHS AR-048267NIAMS NIH HHS R01 AR048267
6 · The paper itself

Abstract

Angiogenesis is the formation of new capillaries from pre-existing vessels. A number of soluble and cell-bound factors may stimulate neovascularization. The perpetuation of angiogenesis involving numerous soluble and cell surface-bound mediators has been associated with rheumatoid arthritis (RA). These angiogenic mediators, among others, include growth factors, primarily vascular endothelial growth factor (VEGF) and hypoxia-inducible factors (HIFs), as well as pro-inflammatory cytokines, various chemokines, cell adhesion molecules, proteases and others. Among the several potential angiogenesis inhibitors, targeting of VEGF, HIF-1, angiopoietin and the alpha(V)beta(3) integrin, as well as some endogenous or synthetic compounds including angiostatin, endostatin, paclitaxel, fumagillin analogues, 2-methoxyestradiol and thalidomide seems to be promising for the management of synovial inflammation and angiogenesis. A complete review of antiangiogenic drugs used in animal models of arthritis or human RA is available in a table.

Indexed as

Angiogenesis InhibitorsAnimalsArthritis, RheumatoidDisease Models, AnimalHumansNeovascularization, PathologicSynovial MembraneVascular Endothelial Growth Factor AAngiogenesis InhibitorsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID20022538
PMCPMC2910514
OpenAlexW2041304170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.